-
-
7 . Academic Journal
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
- 저자
- by Afzali, Anita; Aitova, Lilia; Aldeguer i Mante, Xavier; Allez, Matthieu; Altorjay, István, et al.
- 소스
- In The Lancet 11 June 2022 399(10342):2200-2211
-
7 . Periodical
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
- 저자
- by Sands, Bruce E; Irving, Peter M; Hoops, Timothy; Izanec, James L; Gao, Long-Long, et al.
- 소스
- The Lancet; June 2022, Vol. 399 Issue: 10342 p2200-2211, 12p